Novo A/S

Novo A/S

 

 

Novo A/S is a Danish private limited liability company wholly owned by the Novo Nordisk Foundation, and the holding company of the Novo Group and as such the majority shareholder in the publicly listed companies Novo Nordisk A/S and Novozymes A/S.

Novo A/S was established in 1999 prior to the demerger of Novo Nordisk A/S, where Novozymes A/S was established as a stand-alone publicly listed company. Novo's purpose and objectives are to manage the Foundation's financial assets and to ensure the Foundation sufficient dividends to cover its grant obligations for medical and scientific research etc. in Scandinavia. Besides the holdings in Novo Nordisk and Novozymes Novo A/S manages a large portfolio of seeds, venture and growth equity companies within the life science sector, plus a globally diversified portfolio of financial investments.

 

诺和股份有限公司乃是一家丹麦私营有限责任公司,它是诺和诺德基金会下属的一家全资子公司,是诺和集团下属的一家控股公司,其主要股东是两级上市公司,即诺和诺德有限公司和诺维信有限公司。

诺和股份有限公司成立于诺和诺德股份有限公司发生合并解散之前的1999年,维信有限公司成为一家独立上市公司。诺和的目的和目标是管理基金会的金融资产,并确保基金会有足够的分红来支付在斯堪的纳维亚半岛的医疗和科研方面的拨款义务。除了在诺和诺德有限公司和诺维信有限公司的股份以外,诺和股份有限公司还管理者包括生命科学领域内的种子、合资公司和增长股本公司在内大量资产组合,以及全球范围的、多样化的金融投资组合资产。

Website: http://www.novo.dk